The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes

Diabetic Medicine

Volumn 28, Issue 8, 2011, Pages 972-975

  Corrado, F ^a   D'Anna, R ^a   di Vieste, G ^a   Giordano, D ^a   Pintaudi, B ^a   Santamaria, A ^a   di Benedetto, A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Adiponectin; Gestational diabetes; Homeostasis model assessment of insulin resistance; Insulin resistance; Myoinositol

Indexed keywords

ADIPONECTIN; FOLIC ACID; GLUCOSE; INOSITOL; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INOSITOL; INSULIN; INSULIN RESISTANCE; PREGNANCY; TREATMENT OUTCOME;

EID: 79960258634     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03284.x     Document Type: Article

References (17)

1. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
2. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 1990; 323: 373-378.
3. Suzuki S, Kawasaki H, Satoh Y. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese typeII diabetes. Diabetes Care 1994; 17: 1465-1468.
4. Scioscia M, Kunjara S, Gumaa K, McLean P, Rodeck CH, Rademacher TW. Urinary excretion of inositol phosphoglycan p-type in gestational diabetes mellitus. Diabet Med 2007; 24: 1300-1304.
5. Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE Jr, Apridonidze T, Iuorno MJ, Nestler JE. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 2006; 29: 300-305.
6. Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C et al. Myoinositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 2007; 23: 700-703.
7. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the policistic ovary syndrome. N Engl J Med 1999; 340: 1314-1320.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31: S55-S60.
9. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
10. D'Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG 2006; 113: 1264-1269.
11. Tsai PJ, Yu CH, Hsu SP, Lee YH, Huang IT, Ho SC, Chu CH. Maternal plasma adiponectin concentrations at 24-31weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005; 21: 1095-1099.
12. Catalano PM, Hoegh M, Minium J, Houston-Presley L, Bernard S, Kalhan S et al. Adiponectin in human pregnancy: implication for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677-1685.
13. Gennazzani A, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 2008; 24: 139-144.
14. Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004; 19: 510-521.
15. Cheang KI, Baillargeon JP, Essah PA, Ostlund RE, Apridonize T, Nestler JE. Insulin stimulated release of D-chiro-inositol containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism 2008; 57: 1390-1397.
16. Saltiel AR. Second messengers of insulin action. Diabetes Care 1990; 13: 244-256.
17. Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE. Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metab Syndr Relat Disord 2010; 8: 127-136.